1,4-dioxaspiro[4.4]nonane-6-carboxylic acid, 95%, 100mg

Perhydrofluorene, 98%, 250mg

(R)-1-(4-Chloro-3-fluorophenyl)ethanaminehydrochloride, 95.0%, 1g

2-(1-(tert-Butoxycarbonyl)-4-hydroxypiperidin-4-yl)acetic acid, 95.0%, 100mg

4-(4-Fluorobenzyloxy)benzaldehyde, 95.0%, 250mg

tert-butyl 4-{[(3-aminopyrazin-2-yl)carbonyl]amino}piperidine-1-carboxylate, 50mg

3-(2-Bromophenyl)-2,2-dimethylpropanoic acid, 98%, 500mg

DBD-COCl [=4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling]>93.0%(T)100mg

2-Bromonaphthalen-1-ol, 95.0%, 5g

5-Chloro-2-methoxypyridin-3-amine, 95.0%, 100g

Di-tert-butyl dicarbonate, 97.0%, 100g

3-(4-Aminopiperidine-1-carbonyl)phenol hydrochloride, 98%, 50mg

(6-Fluorobenzo[d]isoxazol-3-yl)methanamine, 98%, 250mg